Retension Pharmaceuticals (RTSN) Financials: Revenue & Earnings
RTSN$13.41-0.11 -0.81%
$50.29M
Market Cap
—
P/E
—
Forward P/E
—
Score
Retension Pharmaceuticals (RTSN) Financials: Revenue & Earnings
RTSN price $13.41 -0.11 -0.81%
- Ticker
- RTSN
- Price
- $13.41
- Change
- -0.11 -0.81%
- Market cap ?
- $50.29M
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
Fair value
RTSN fair value Not meaningful. Price $13.41.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| No data yet. | ||||
Dividends
Yield —. Payout ratio —. Frequency —.
Safety score 34/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. Yield is unknown, so this part stays neutral.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-22 | Keller Eric L. | Buy | 40.88K | $15.50 | 633.70K |
| 2026-10-13 | B Group, Inc. | Other | 0 | — | — |
| 2026-10-13 | Keller Eric L. | Buy | 31.37K | — | — |
| 2026-10-13 | Keller Eric L. | Buy | 9.66K | — | — |
| 2026-10-13 | Keller Eric L. | Buy | 20.80K | $12.00 | 249.60K |
| 2026-10-13 | Keller Eric L. | Buy | 255.17K | $11.63 | 2.97M |
| 2026-10-13 | Keller Eric L. | Sell | 9.66K | — | — |
| 2026-10-13 | Keller Eric L. | Sell | 31.37K | — | — |
| 2026-10-13 | Sweetnam Paul | Buy | 4.03K | — | — |
| 2026-10-13 | Sweetnam Paul | Buy | 2.64K | — | — |
| 2026-10-13 | Sweetnam Paul | Sell | 4.03K | — | — |
| 2026-10-13 | Sweetnam Paul | Sell | 2.64K | — | — |
| 2026-10-13 | Olds Donald | Buy | 5.64K | — | — |
| 2026-10-13 | Olds Donald | Sell | 5.64K | — | — |
| 2026-10-13 | Cheruvu Pavan | Buy | 5.64K | $11.63 | 65.55K |
| 2026-10-13 | Bisson Sabine | Buy | 2.50K | — | — |
| 2026-10-13 | Bisson Sabine | Buy | 1.61K | — | — |
| 2026-10-13 | Bisson Sabine | Sell | 1.61K | — | — |
| 2026-10-13 | Bisson Sabine | Sell | 2.50K | — | — |
| 2026-10-13 | BERGER FRANKLIN M | Buy | 12.52K | — | — |
| 2026-10-13 | BERGER FRANKLIN M | Buy | 10.00K | $12.00 | 120.00K |
| 2026-10-13 | BERGER FRANKLIN M | Sell | 12.52K | — | — |
| 2026-10-13 | BERENDT MICHAEL J | Buy | 2.64K | — | — |
| 2026-10-13 | BERENDT MICHAEL J | Buy | 4.03K | — | — |
| 2026-10-13 | BERENDT MICHAEL J | Sell | 4.03K | — | — |
| 2026-10-13 | BERENDT MICHAEL J | Sell | 2.64K | — | — |
| 2026-10-13 | Cheruvu Pavan | Other | 0 | — | — |
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Earnings and financials
Retension Pharmaceuticals Inc. (RTSN) trades at $13.41, with a market cap of $50.29M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn